Sampath Anand Insider Trading Activity (MASI)

Summary

Updated Jul 16, 2026

Sampath Anand has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $2.56M.

Profile

Anand Sampath is an executive at Masimo Corp (MASI) who, according to the latest SEC filing dated 2026-01-31, serves as Executive Vice President of Operations and Clinical Research. In this role, he oversees Masimo's manufacturing operations and clinical research initiatives, contributing to the company's healthcare technology development. The SEC filing indicates no equity purchases or sales by Mr. Sampath in that period.

Role	EVP, Operations
Notability	40/100

Board memberships

Masimo Corp (MASI)

Awards & honors

Oversees operations and clinical research programs for Masimo
Drives operational efficiency and scalability of Masimo's product development
Leads clinical research initiatives in support of healthcare technology

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-06-12	MASI	MASIMO CORP	D — Derivative transaction	33.9K	$180.00	$6.10M
2026-01-31	MASI	MASIMO CORP	S — Open-market sale [10b5-1]	196	$138.09	$27K
2026-01-31	MASI	MASIMO CORP	S — Open-market sale [10b5-1]	6.6K	$137.22	$900K
2026-01-31	MASI	MASIMO CORP	S — Open-market sale [10b5-1]	11.9K	$136.56	$1.63M
2026-01-31	MASI	MASIMO CORP	M — Option exercise [10b5-1]	30.0K	$37.84	$1.14M

Frequently Asked Questions

Who is Sampath Anand?

How many SEC Form 4 filings has Sampath Anand submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Sampath Anand been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 3 open-market sales ($2.56M) across all tracked filings.

Where can I see all of Sampath Anand's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Sampath Anand — SEC Form 4 Insider Trading Activity